Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212766744> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4212766744 abstract "Introduction: Heart Failure (HF) is categorized according to the AHA/ACC 2013 HF Guidelines based on Left Ventricular Ejection Fraction (LVEF); HF with Reduced Ejection Fraction (HFrEF, EF≤40%), and HF with preserved EF (HFpEF, EF ≥ 50%). There is a group of “borderline” patients with EF 41%-49%, termed Heart Failure with Mid-Range Ejection Fraction (HFmrEF). Given this category is not well understood, we sought to evaluate clinical characteristics and management patterns for patients with HFmrEF. Methods: A systematic review was performed using Ovid MEDLINE, EMBASE, Cochrane CENTRAL and LILACS (1946 – 03/2018). Search terms included HF, mid-range, borderline LVEF with several ranges (40-50 or 40-45 or 45-50). Variables characterizing clinical features and medications were extracted for each HF group and adjusted odds ratios (ORs) were pooled. Results: Of 1,131 abstracts identified, 24 met inclusion criteria (total patients 480,188). Patients with HFmrEF compared to those with HFrEF were more likely to be female (OR 1.42), have hypertension [HTN] (OR 1.34) and diabetes (OR 1.11), higher SBP (OR 1.17), better NYHA-FC (FC I OR 1.73, FC II 1.33), less likely to have coronary artery disease [CAD] (OR 0.74) and more likely to be treated with ACEI, ARB, BB, Digoxin, MRA and statins (Figure 1-2). HFmrEF patients when compared to those with HFpEF were less likely to be female (OR 0.54) or have HTN (OR 0.68), and more likely to have CAD (OR 1.25), and to be treated with HF medications and statins. Conclusions: Patients with HFmrEF have higher SBP and better NYHA-FC (I and II) compared to HFrEF patients and are less likely to be female and more likely to have CAD compared to HFpEF patients. Further research is needed to help guide management in this unique but clinically important population. Figure 1A. Forest plot of adjusted ORs comparing baseline clinical characteristics of HFrEF vs HFmrEF patients Figure 1B. Forest plot of adjusted ORs comparing baseline clinical characteristics of HFmrEF vs HFpEF patients Figure 2A. Forest plot of adjusted ORs comparing medications used in HFrEF vs HFmrEF patients Figure 2B. Forest plot of adjusted ORs comparing medications used in HFmrEF vs HFpEF patients" @default.
- W4212766744 created "2022-02-24" @default.
- W4212766744 creator A5000139324 @default.
- W4212766744 creator A5007483734 @default.
- W4212766744 creator A5021262240 @default.
- W4212766744 creator A5038677955 @default.
- W4212766744 creator A5048628851 @default.
- W4212766744 creator A5049210394 @default.
- W4212766744 creator A5054219244 @default.
- W4212766744 creator A5086345352 @default.
- W4212766744 creator A5089151144 @default.
- W4212766744 date "2018-11-06" @default.
- W4212766744 modified "2023-09-26" @default.
- W4212766744 title "Abstract 17284: Clinical Characteristics and Management of Patients With Heart Failure With Mid-Range Ejection Fraction: A Systematic Review and Meta-Analysis" @default.
- W4212766744 doi "https://doi.org/10.1161/circ.138.suppl_1.17284" @default.
- W4212766744 hasPublicationYear "2018" @default.
- W4212766744 type Work @default.
- W4212766744 citedByCount "0" @default.
- W4212766744 crossrefType "journal-article" @default.
- W4212766744 hasAuthorship W4212766744A5000139324 @default.
- W4212766744 hasAuthorship W4212766744A5007483734 @default.
- W4212766744 hasAuthorship W4212766744A5021262240 @default.
- W4212766744 hasAuthorship W4212766744A5038677955 @default.
- W4212766744 hasAuthorship W4212766744A5048628851 @default.
- W4212766744 hasAuthorship W4212766744A5049210394 @default.
- W4212766744 hasAuthorship W4212766744A5054219244 @default.
- W4212766744 hasAuthorship W4212766744A5086345352 @default.
- W4212766744 hasAuthorship W4212766744A5089151144 @default.
- W4212766744 hasConcept C126322002 @default.
- W4212766744 hasConcept C134018914 @default.
- W4212766744 hasConcept C156957248 @default.
- W4212766744 hasConcept C164705383 @default.
- W4212766744 hasConcept C2777099384 @default.
- W4212766744 hasConcept C2777707475 @default.
- W4212766744 hasConcept C2778198053 @default.
- W4212766744 hasConcept C2778213512 @default.
- W4212766744 hasConcept C555293320 @default.
- W4212766744 hasConcept C71924100 @default.
- W4212766744 hasConcept C78085059 @default.
- W4212766744 hasConceptScore W4212766744C126322002 @default.
- W4212766744 hasConceptScore W4212766744C134018914 @default.
- W4212766744 hasConceptScore W4212766744C156957248 @default.
- W4212766744 hasConceptScore W4212766744C164705383 @default.
- W4212766744 hasConceptScore W4212766744C2777099384 @default.
- W4212766744 hasConceptScore W4212766744C2777707475 @default.
- W4212766744 hasConceptScore W4212766744C2778198053 @default.
- W4212766744 hasConceptScore W4212766744C2778213512 @default.
- W4212766744 hasConceptScore W4212766744C555293320 @default.
- W4212766744 hasConceptScore W4212766744C71924100 @default.
- W4212766744 hasConceptScore W4212766744C78085059 @default.
- W4212766744 hasIssue "Suppl_1" @default.
- W4212766744 hasLocation W42127667441 @default.
- W4212766744 hasOpenAccess W4212766744 @default.
- W4212766744 hasPrimaryLocation W42127667441 @default.
- W4212766744 hasRelatedWork W2027691053 @default.
- W4212766744 hasRelatedWork W2061321770 @default.
- W4212766744 hasRelatedWork W2104371670 @default.
- W4212766744 hasRelatedWork W2327585969 @default.
- W4212766744 hasRelatedWork W2538662566 @default.
- W4212766744 hasRelatedWork W2900388542 @default.
- W4212766744 hasRelatedWork W2964563167 @default.
- W4212766744 hasRelatedWork W2965474825 @default.
- W4212766744 hasRelatedWork W3033076790 @default.
- W4212766744 hasRelatedWork W3157316619 @default.
- W4212766744 hasVolume "138" @default.
- W4212766744 isParatext "false" @default.
- W4212766744 isRetracted "false" @default.
- W4212766744 workType "article" @default.